TECH insider filings

BIO-TECHNE Corp — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-03. Screen TECH transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 16 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Kelderman Kim — Chief Executive Officer, Director2——11
Hippel James — CFO2——10
Bohnen Shane — SVP - General Counsel1——8
Geist William — PRESIDENT, PROTEIN SCIENCES1——7
BAUMGARTNER ROBERT V — Director2——4
HIGGINS JOHN L — Director2——4
Bushman Julie L — Director1——1
Herr Amy E. — Director1——1
KEEGAN JOSEPH D — Director1——1
Klimovsky Judith V. — Director1——1

+2 more insiders in the window, not shown — every filing appears in the table below.

Recent insider filings — BIO-TECHNE Corp

FiledFormInsiderReported transactionsSource
2026-11-034Hippel James — CFOOption exercise (M): 11,545 @ $0 · Tax withholding (F): 5,096 @ $72.66 · Option exercise (M): 11,545 (derivative) @ $0EDGAR
2026-11-034Kelderman Kim — Chief Executive Officer, DirectorTax withholding (F): 2,385 @ $72.66EDGAR
2026-11-024/AHippel James — CFOOption exercise (M): 9,980 @ $0 · Tax withholding (F): 4,423 @ $72.40 · Disposition to issuer (D): 34,443 (derivative) @ $0 · Option exercise (M): 1,067 (derivative) @ $0 · Disposition to issuer (D): 12,798 (derivative) @ $0 · Option exercise (M): 4,010 (derivative) @ $0 · +1 moreEDGAR
2026-11-024/AKelderman Kim — Chief Executive Officer, DirectorOption exercise (M): 21,736 @ $0 · Tax withholding (F): 10,955 @ $72.40 · Disposition to issuer (D): 22,044 (derivative) @ $0 · Disposition to issuer (D): 23,949 (derivative) @ $0 · Option exercise (M): 683 (derivative) @ $0 · Disposition to issuer (D): 8,190 (derivative) @ $0 · +4 moreEDGAR
2026-11-024/AGeist William — PRESIDENT, PROTEIN SCIENCESOption exercise (M): 6,547 @ $0 · Tax withholding (F): 2,019 @ $72.40 · Disposition to issuer (D): 22,545 (derivative) @ $0 · Disposition to issuer (D): 698 (derivative) @ $0 · Option exercise (M): 8,376 (derivative) @ $0 · Option exercise (M): 2,623 (derivative) @ $0 · +1 moreEDGAR
2026-11-024/ABohnen Shane — SVP - General CounselOption exercise (M): 4,420 @ $0 · Tax withholding (F): 1,366 @ $72.40 · Disposition to issuer (D): 11,929 (derivative) @ $0 · Option exercise (M): 370 (derivative) @ $0 · Disposition to issuer (D): 4,432 (derivative) @ $0 · Option exercise (M): 49 (derivative) @ $0 · +2 moreEDGAR
2026-11-024Herr Amy E. — DirectorGrant/award (A): 2,750 @ $0EDGAR
2026-11-024Klimovsky Judith V. — DirectorGrant/award (A): 2,750 @ $0EDGAR
2026-11-024Seth Alpna — DirectorGrant/award (A): 2,750 @ $0EDGAR
2026-11-024Vessey Rupert — DirectorGrant/award (A): 2,750 @ $0EDGAR
2026-11-024HIGGINS JOHN L — DirectorGrant/award (A): 2,750 @ $0EDGAR
2026-11-024KEEGAN JOSEPH D — DirectorGrant/award (A): 2,750 @ $0EDGAR
2026-11-024BAUMGARTNER ROBERT V — DirectorGrant/award (A): 2,750 @ $0EDGAR
2026-11-024Bushman Julie L — DirectorGrant/award (A): 2,750 @ $0EDGAR
2026-09-304HIGGINS JOHN L — DirectorOption exercise (M): 15,940 @ $0 · Tax withholding (F): 5,562 @ $72.51 · Option exercise (M): 15,940 (derivative) @ $0EDGAR
2026-09-244BAUMGARTNER ROBERT V — DirectorOption exercise (M): 15,940 @ $0 · Tax withholding (F): 5,559 @ $72.55 · Option exercise (M): 15,940 (derivative) @ $0EDGAR
2026-08-194Crouse Steven C. — President - Diag & Spatial BiGrant/award (A): 8,702 (derivative) @ $0 · Grant/award (A): 14,140 (derivative) @ $0EDGAR
2026-08-194Geist William — PRESIDENT, PROTEIN SCIENCESGrant/award (A): 14,762 (derivative) @ $0 · Grant/award (A): 23,985 (derivative) @ $0EDGAR
2026-08-194Herr Amy E. — DirectorGrant/award (A): 1,381 (derivative) @ $0EDGAR
2026-08-194Hippel James — CFOGrant/award (A): 22,438 (derivative) @ $0 · Grant/award (A): 36,459 (derivative) @ $0EDGAR
2026-08-194Kelderman Kim — Chief Executive Officer, DirectorGrant/award (A): 57,590 (derivative) @ $0 · Grant/award (A): 93,582 (derivative) @ $0EDGAR
2026-08-194Bohnen Shane — SVP - General CounselGrant/award (A): 11,344 (derivative) @ $0 · Grant/award (A): 18,432 (derivative) @ $0EDGAR
2026-08-184Hippel James — CFOOption exercise (M): 9,779 @ $0 · Tax withholding (F): 4,310 @ $72.40 · Option exercise (M): 866 (derivative) @ $0 · Disposition to issuer (D): 12,999 (derivative) @ $0 · Disposition to issuer (D): 34,982 (derivative) @ $0 · Option exercise (M): 4,010 (derivative) @ $0 · +1 moreEDGAR
2026-08-184Kelderman Kim — Chief Executive Officer, DirectorOption exercise (M): 21,470 @ $0 · Tax withholding (F): 10,821 @ $72.40 · Option exercise (M): 554 (derivative) @ $0 · Disposition to issuer (D): 8,319 (derivative) @ $0 · Disposition to issuer (D): 22,389 (derivative) @ $0 · Option exercise (M): 588 (derivative) @ $0 · +4 moreEDGAR
2026-08-184Geist William — PRESIDENT, PROTEIN SCIENCESOption exercise (M): 6,416 @ $0 · Tax withholding (F): 1,976 @ $72.40 · Option exercise (M): 567 (derivative) @ $0 · Disposition to issuer (D): 8,507 (derivative) @ $0 · Disposition to issuer (D): 22,898 (derivative) @ $0 · Option exercise (M): 2,623 (derivative) @ $0 · +1 moreEDGAR
2026-08-184Bohnen Shane — SVP - General CounselOption exercise (M): 4,350 @ $0 · Tax withholding (F): 1,343 @ $72.40 · Option exercise (M): 49 (derivative) @ $0 · Disposition to issuer (D): 12,117 (derivative) @ $0 · Option exercise (M): 300 (derivative) @ $0 · Disposition to issuer (D): 4,502 (derivative) @ $0 · +2 moreEDGAR
2026-08-184Herr Amy E. — DirectorOption exercise (M): 589 @ $0 · Tax withholding (F): 213 @ $72.40 · Option exercise (M): 118 (derivative) @ $0 · Option exercise (M): 160 (derivative) @ $0 · Option exercise (M): 311 (derivative) @ $0EDGAR
2026-08-184Crouse Steven C. — President - Diag & Spatial BiOption exercise (M): 5,423 @ $0 · Tax withholding (F): 1,947 @ $72.40 · Option exercise (M): 1,379 (derivative) @ $0 · Option exercise (M): 1,868 (derivative) @ $0 · Option exercise (M): 2,176 (derivative) @ $0EDGAR
2026-07-314Hippel James — CFOOption exercise (M): 62,068 @ $47.60 · Tax withholding (F): 51,024 @ $72.03 · Option exercise (M): 62,068 (derivative) @ $0EDGAR
2026-07-304Kelderman Kim — Chief Executive Officer, DirectorOption exercise (M): 35,000 @ $47.60 · Tax withholding (F): 28,686 @ $72.07 · Option exercise (M): 35,000 (derivative) @ $0EDGAR
2026-07-274Bohnen Shane — SVP - General CounselOption exercise (M): 448 @ $47.60 · Tax withholding (F): 344 @ $71.77 · Option exercise (M): 448 (derivative) @ $0EDGAR
2026-06-044Crouse Steven C. — President - Diag & Spatial BiOption exercise (M): 600 · Tax withholding (F): 216 @ $49.77 · Option exercise (M): 600 (derivative) @ $0EDGAR
2026-05-124Herr Amy E. — DirectorOption exercise (M): 6,636 @ $47.60 · Sale (S): 6,636 @ $48.28 · Option exercise (M): 6,636 (derivative) @ $0EDGAR
2026-05-074Bohnen Shane — SVP - General CounselOption exercise (M): 8,400 @ $47.60 · Tax withholding (F): 7,055 @ $56.68 · Option exercise (M): 8,400 (derivative) @ $0EDGAR
2026-05-074Kelderman Kim — Chief Executive Officer, DirectorOption exercise (M): 26,692 @ $47.60 · Tax withholding (F): 23,951 @ $56.68 · Option exercise (M): 26,692 (derivative) @ $0EDGAR
2026-05-074Hippel James — CFOOption exercise (M): 62,000 @ $47.60 · Tax withholding (F): 56,955 @ $56.68 · Option exercise (M): 62,000 (derivative) @ $0EDGAR
2026-05-054Crouse Steven C. — President - Diag & Spatial BiOption exercise (M): 794 · Tax withholding (F): 311 @ $55.02 · Option exercise (M): 794 (derivative) @ $0EDGAR
2026-04-244Kelderman Kim — Chief Executive Officer, DirectorOption exercise (M): 11,344 @ $0 · Tax withholding (F): 1,363 @ $58.58 · Option exercise (M): 11,344 (derivative) @ $0EDGAR
2026-04-244Hippel James — CFOOption exercise (M): 62,000 @ $0 · Tax withholding (F): 56,097 @ $58.58 · Option exercise (M): 62,000 (derivative) @ $0EDGAR
2026-04-164Kelderman Kim — Chief Executive Officer, DirectorOption exercise (M): 36,500 @ $0 · Tax withholding (F): 32,088 @ $58.66 · Option exercise (M): 36,500 (derivative) @ $0EDGAR
2026-04-074Bohnen Shane — SVP - General CounselOption exercise (M): 2,259 @ $0 · Tax withholding (F): 740 @ $53.13 · Option exercise (M): 2,259 (derivative) @ $0EDGAR
2026-03-044Crouse Steven C. — President - Diag & Spatial BiGrant/award (A): 2,387 (derivative) @ $0 · Grant/award (A): 735 (derivative) @ $0 · Grant/award (A): 1,911 (derivative) @ $0EDGAR
2026-02-194Herr Amy E. — DirectorSale (S): 1,976 @ $59.10EDGAR
2026-02-054Herr Amy E. — DirectorOption exercise (M): 38 @ $0 · Tax withholding (F): 16 @ $64.63 · Option exercise (M): 38 (derivative) @ $0EDGAR
2026-02-034McManus Matthew — President - Diag & Spatial BioOption exercise (M): 4,621 @ $0 · Tax withholding (F): 1,665 @ $64.09 · Option exercise (M): 4,621 (derivative) @ $0EDGAR
2025-11-054Geist William — PRESIDENT, PROTEIN SCIENCESOption exercise (M): 9,911 @ $0 · Tax withholding (F): 4,520 @ $62.57 · Option exercise (M): 9,911 (derivative) @ $0EDGAR
2025-11-054Kelderman Kim — Chief Executive Officer, DirectorTax withholding (F): 2,303 @ $62.57EDGAR
2025-11-054Hippel James — CFOOption exercise (M): 13,159 @ $0 · Option exercise (M): 11,545 @ $0 · Tax withholding (F): 11,865 @ $62.57 · Option exercise (M): 13,159 (derivative) @ $0 · Option exercise (M): 11,545 (derivative) @ $0EDGAR
2025-11-034BAUMGARTNER ROBERT V — DirectorGrant/award (A): 1,640 @ $0 · Grant/award (A): 3,777 (derivative) @ $0EDGAR
2025-11-034HIGGINS JOHN L — DirectorGrant/award (A): 1,640 @ $0 · Grant/award (A): 3,777 (derivative) @ $0EDGAR

Recent 8-K events — BIO-TECHNE Corp

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-048-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-238-K5.07 — Submission of Matters to a Vote of Security Holders
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-148-K8.01 — Other EventsEDGAR
2026-08-128-K2.02 — Results of Operations and Financial Condition
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-268-K1.01 — Entry into a Material Definitive Agreement
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-258-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-068-K2.02 — Results of Operations and Financial Condition
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-118-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-048-K2.02 — Results of Operations and Financial Condition
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-11-058-K2.02 — Results of Operations and Financial Condition
5.07 — Submission of Matters to a Vote of Security Holders
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=TECH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs